C84.42 ICD-10-CM Code: Peripheral T-cell lymphoma, not elsewhere classified, intrathoracic lymph nodes
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C84.42
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidancePeripheral T-cell lymphoma, not elsewhere classified, intrathoracic lymph nodes
A type of T-cell lymphoma affecting the lymph nodes inside the chest cavity.

Buddy Insight
Peripheral T-cell lymphoma not elsewhere classified involving intrathoracic lymph nodes represents an aggressive non-Hodgkin lymphoma subtype with poor prognosis.
CMS-HCC V28
MappedHCC 19
RAF 0.105
CMS-HCC V24
MappedHCC 10
RAF 0.675
ACA/HHS
00
RAF 0
ESRD/PACE
MappedHCC 10
RAF 0.0
RXHCC
MappedHCC 21
RAF 0.0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
Official- Lennert's lymphoma
- Lymphoepithelioid lymphoma
- Mature T-cell lymphoma, not elsewhere classified
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for C84.42 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for C84.42 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for C84.42 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for C84.42 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for C84.42 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for C84.42 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is C84.42 an HCC code?
Yes. C84.42 maps to Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model (and Lymphoma and Other Cancers under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for C84.42
For C84.42to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C84.42 during that encounter, not just copy-forwarded from a problem list.
What This Code Means
C84.42 is the ICD-10-CM diagnosis code for peripheral t-cell lymphoma, not elsewhere classified, intrathoracic lymph nodes. A type of T-cell lymphoma affecting the lymph nodes inside the chest cavity. C84.42 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of lymphoid, hematopoietic and related tissue (c81-c96).
Under the CMS-HCC V28 risk adjustment model, C84.42 maps to Lymphoma and Other Cancers (HCC 19) with a community, non-dual, aged base RAF weight of 0.105. Under the older V24 model, C84.42 mapped to the same category but with a base RAF weight of 0.675, V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Verify documentation confirms intrathoracic (within the chest) lymph node involvement. Because C84.42 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C84.42 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Verify documentation confirms intrathoracic (within the chest) lymph node involvement
- •This includes mediastinal and hilar lymph nodes
Clinical Significance
Peripheral T-cell lymphoma not elsewhere classified involving intrathoracic lymph nodes represents an aggressive non-Hodgkin lymphoma subtype with poor prognosis. Site-specific coding is critical because intrathoracic involvement may indicate mediastinal bulky disease, which affects staging and treatment approach. Accurate capture ensures appropriate resource allocation for this high-acuity malignancy.
Documentation Requirements
- ✓Pathology report confirming peripheral T-cell lymphoma, NOS (not a more specific T-cell lymphoma subtype)
- ✓Imaging (CT or PET/CT) documenting intrathoracic lymph node involvement (mediastinal, hilar, or paratracheal nodes)
- ✓Immunohistochemistry panel showing T-cell markers (CD3+, CD4+ or CD8+) and excluding other specific T-cell lymphoma subtypes
- ✓Current treatment status and clinical stage (Ann Arbor staging system)
- ✓Documentation that this is active disease, not in remission
Commonly Confused Codes
- •C84.62 — Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes: ALCL is a specific subtype with distinct morphology (hallmark cells) and ALK expression; PTCL-NOS is a diagnosis of exclusion when no specific T-cell lymphoma subtype fits
- •C84.72 — Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes: ALK-negative ALCL has specific morphologic features distinguishing it from PTCL-NOS
- •C85.12 — Unspecified B-cell lymphoma, intrathoracic lymph nodes: B-cell lineage must be excluded through immunophenotyping before assigning a T-cell lymphoma code
- •C84.48 — PTCL-NOS, lymph nodes of multiple sites: Use C84.42 only when involvement is limited to intrathoracic nodes; if other regions are also involved, C84.48 is appropriate